2019, Number 3
<< Back Next >>
Acta Med 2019; 17 (3)
Raynaud’s phenomenon secondary to carbamazepine
Alcocer MJL, Damián AG
Language: Spanish
References: 4
Page: 294-295
PDF size: 116.48 Kb.
Text Extraction
No abstract.
REFERENCES
Bouquet É, Urbanski G, Lavigne C, Lainé-Cessac P. Unexpected drug-induced Raynaud phenomenon: analysis from the French national pharmacovigilance database. Therapie. 2017; 72 (5): 547-554.
Merikangas JR, Auchenbach R. Carbamazepine in Raynaud’s disease. Lancet. 1977; 2 (8049): 1186.
Reiffers-Mettelock J, Hentges F, Humbel RL. Syndrome resembling systemic lupus erythematosus induced by carbamazepine. Dermatology. 1997; 195 (3): 306.
Alarcón-Segovia D, Fishbein E, Reyes PA, Díes H, Shwadsky S. Antinuclear antibodies in patients on anticonvulsant therapy. Clin Exp Immunol. 1972; 12 (1): 39-47.
Full text